1. Home
  2. IMNM vs TRN Comparison

IMNM vs TRN Comparison

Compare IMNM & TRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$28.01

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo Trinity Industries Inc.

TRN

Trinity Industries Inc.

HOLD

Current Price

$29.69

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
TRN
Founded
2006
1933
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Railroads
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
IMNM
TRN
Price
$28.01
$29.69
Analyst Decision
Strong Buy
Hold
Analyst Count
10
1
Target Price
$32.80
$34.00
AVG Volume (30 Days)
1.1M
732.2K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
4.03%
EPS Growth
51.40
85.98
EPS
N/A
1.50
Revenue
$6,941,000.00
$2,156,900,000.00
Revenue This Year
N/A
$1.91
Revenue Next Year
$1,127.34
$15.61
P/E Ratio
N/A
$19.86
Revenue Growth
N/A
N/A
52 Week Low
$8.67
$24.76
52 Week High
$30.06
$38.31

Technical Indicators

Market Signals
Indicator
IMNM
TRN
Relative Strength Index (RSI) 62.76 36.02
Support Level $18.72 $28.81
Resistance Level N/A $30.32
Average True Range (ATR) 1.51 0.89
MACD 0.15 0.04
Stochastic Oscillator 66.25 26.44

Price Performance

Historical Comparison
IMNM
TRN

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About TRN Trinity Industries Inc.

Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.

Share on Social Networks: